From April 1, 2024 to June 30, 2024, the company has repurchased 1,895,250 shares, representing 0.72% for CNY 12.59 million. With this, the company has completed the repurchase of 2,968,800 shares, representing 1.13% for CNY 19.99 million under the buyback announced on February 7, 2024.
Guangdong Biolight Meditech Co., Ltd.
Equities
300246
CNE1000015Q4
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.67 CNY | -3.90% |
|
-5.50% | -44.95% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.95% | 214M | |
-7.22% | 181B | |
-6.72% | 99.52B | |
-7.50% | 65.82B | |
-10.57% | 45.21B | |
+8.92% | 43.85B | |
+11.01% | 42.17B | |
+9.65% | 28.75B | |
+18.54% | 25.39B | |
-9.13% | 23.5B |
- Stock Market
- Equities
- 300246 Stock
- News Guangdong Biolight Meditech Co., Ltd.
- Tranche Update on Guangdong Biolight Meditech Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024.